CITADEL ADVISORS LLC historic quarter change: USA Bonds: Other Debt, Reduced
In other debt filed by principal amount (debentures, bonds) (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 884 positions, added to 1,270, reduced 1,104 and sold out of 996.
- Q1 2017: Stock MOLINA HEALTHCARE INC; Country of operation —; Class Bond; Principal before $55,500,000.
- Q1 2017: Stock TELEFLEX INC; Country of operation —; Class Bond; Principal before $17,339,000.
- Q1 2017: Stock CONVERGYS CORP; Country of operation —; Class Bond; Principal before $40,549,000.
- Q1 2017: Stock ISIS PHARMACEUTICALS INC DEL; Country of operation —; Class Bond; Principal before $35,457,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Principal before | Principal after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q1 2017 | MOLINA HEALTHCARE INC
CUSIP 60855RAC4 | — | Bond | $55,500,000 | $27,000,000 | -28,500,000 | $79,782 | $34,508 | -$45,274 | 2017-05-12 |
|---|
| Q1 2017 | TELEFLEX INC
CUSIP 879369AA4 | — | Bond | $17,339,000 | $2,375,000 | -14,964,000 | $45,459 | $7,485 | -$37,974 | 2017-05-12 |
|---|
| Q1 2017 | CONVERGYS CORP
CUSIP 212485AE6 | — | Bond | $40,549,000 | $27,549,000 | -13,000,000 | $91,684 | $54,577 | -$37,107 | 2017-05-12 |
|---|
| Q1 2017 | ISIS PHARMACEUTICALS INC DEL
CUSIP 464337AJ3 | — | Bond | $35,457,000 | $9,957,000 | -25,500,000 | $36,003 | $9,603 | -$26,400 | 2017-05-12 |
|---|
| Q1 2017 | TESARO INC
CUSIP 881569AA5 | — | Bond | $22,500,000 | $15,121,000 | -7,379,000 | $87,342 | $67,062 | -$20,280 | 2017-05-12 |
|---|
| Q1 2017 | AMAG PHARMACEUTICALS INC
CUSIP 00163UAA4 | — | Bond | $19,000,000 | $7,500,000 | -11,500,000 | $26,904 | $8,194 | -$18,710 | 2017-05-12 |
|---|
| Q1 2017 | TWITTER INC
CUSIP 90184LAB8 | — | Bond | $27,500,000 | $10,000,000 | -17,500,000 | $25,829 | $9,408 | -$16,421 | 2017-05-12 |
|---|
| Q1 2017 | ACETO CORP
CUSIP 004446AD2 | — | Bond | $16,560,000 | $1,250,000 | -15,310,000 | $16,003 | $1,151 | -$14,852 | 2017-05-12 |
|---|
| Q1 2017 | CEMEX SAB DE CV
CUSIP 151290BC6 | — | Bond | $63,300,000 | $50,300,000 | -13,000,000 | $71,161 | $58,768 | -$12,393 | 2017-05-12 |
|---|
| Q1 2017 | ENDOLOGIX INC
CUSIP 29266SAB2 | — | Bond | $31,800,000 | $16,800,000 | -15,000,000 | $27,808 | $16,555 | -$11,253 | 2017-05-12 |
|---|
| Q1 2017 | ENCORE CAP GROUP INC
CUSIP 292554AD4 | — | Bond | $13,000,000 | $3,500,000 | -9,500,000 | $14,013 | $3,858 | -$10,155 | 2017-05-12 |
|---|
| Q1 2017 | RAMBUS INC DEL
CUSIP 750917AE6 | — | Bond | $17,848,000 | $10,848,000 | -7,000,000 | $22,120 | $12,964 | -$9,156 | 2017-05-12 |
|---|
| Q1 2017 | FIDELITY NATIONAL FINANCIAL
CUSIP 31620RAE5 | — | Bond | $40,290,000 | $31,415,000 | -8,875,000 | $78,124 | $69,198 | -$8,926 | 2017-05-12 |
|---|
| Q1 2017 | INOTEK PHARMACEUTICALS CORP
CUSIP 45780VAB8 | — | Bond | $15,000,000 | $10,500,000 | -4,500,000 | $15,394 | $6,476 | -$8,918 | 2017-05-12 |
|---|
| Q1 2017 | TESLA INC
CUSIP 88160RAC5 | — | Bond | $13,500,000 | $3,000,000 | -10,500,000 | $11,722 | $2,947 | -$8,775 | 2017-05-12 |
|---|
| Q1 2017 | MERCADOLIBRE INC
CUSIP 58733RAB8 | — | Bond | $32,178,000 | $30,178,000 | -2,000,000 | $44,388 | $52,509 | +$8,121 | 2017-05-12 |
|---|
| Q1 2017 | TESLA INC
CUSIP 88160RAB7 | — | Bond | $32,500,000 | $22,500,000 | -10,000,000 | $30,139 | $22,475 | -$7,664 | 2017-05-12 |
|---|
| Q1 2017 | J2 GLOBAL INC
CUSIP 48123VAC6 | — | Bond | $89,189,000 | $81,689,000 | -7,500,000 | $117,987 | $110,548 | -$7,439 | 2017-05-12 |
|---|
| Q1 2017 | JANUS CAP GROUP INC
CUSIP 47102XAH8 | — | Bond | $6,368,000 | $868,000 | -5,500,000 | $8,385 | $1,137 | -$7,248 | 2017-05-12 |
|---|
| Q1 2017 | AMTRUST FINL SVCS INC
CUSIP 032359AG6 | — | Bond | $31,500,000 | $27,650,000 | -3,850,000 | $27,182 | $20,500 | -$6,682 | 2017-05-12 |
|---|
| Q1 2017 | VECTOR GROUP LTD
CUSIP 92240MAY4 | — | Bond | $35,000,000 | $33,000,000 | -2,000,000 | $54,637 | $47,962 | -$6,675 | 2017-05-12 |
|---|
| Q1 2017 | ACORDA THERAPEUTICS INC
CUSIP 00484MAA4 | — | Bond | $13,632,000 | $6,257,000 | -7,375,000 | $10,391 | $5,328 | -$5,063 | 2017-05-12 |
|---|
| Q1 2017 | CLOVIS ONCOLOGY INC
CUSIP 189464AB6 | — | Bond | $16,000,000 | $9,000,000 | -7,000,000 | $16,495 | $11,631 | -$4,864 | 2017-05-12 |
|---|
| Q1 2017 | WEBMD HEALTH CORP
CUSIP 94770VAK8 | — | Bond | $19,700,000 | $15,000,000 | -4,700,000 | $22,266 | $17,811 | -$4,455 | 2017-05-12 |
|---|
| Q1 2017 | INTERCEPT PHARMACEUTICALS IN
CUSIP 45845PAA6 | — | Bond | $49,100,000 | $43,100,000 | -6,000,000 | $44,104 | $40,244 | -$3,860 | 2017-05-12 |
|---|
| Q1 2017 | COMCAST HOLDINGS CORP
CUSIP 200300507 | — | Bond | $86,087,552 | $78,835,209 | -7,252,343 | $60,184 | $56,492 | -$3,692 | 2017-05-12 |
|---|
| Q1 2017 | ENDOLOGIX INC
CUSIP 29266SAA4 | — | Bond | $6,230,000 | $2,020,000 | -4,210,000 | $5,624 | $1,950 | -$3,674 | 2017-05-12 |
|---|
| Q1 2017 | SUCAMPO PHARMACEUTICALS INC
CUSIP 864909AA4 | — | Bond | $13,500,000 | $11,500,000 | -2,000,000 | $14,339 | $11,395 | -$2,944 | 2017-05-12 |
|---|
| Q1 2017 | PDL BIOPHARMA INC
CUSIP 69329YAG9 | — | Bond | $11,500,000 | $8,000,000 | -3,500,000 | $9,379 | $7,038 | -$2,341 | 2017-05-12 |
|---|
| Q1 2017 | COBALT INTL ENERGY INC
CUSIP 19075FAA4 | — | Bond | $20,500,000 | $18,000,000 | -2,500,000 | $8,218 | $5,927 | -$2,291 | 2017-05-12 |
|---|
| Q1 2017 | GSV CAP CORP
CUSIP 36191JAB7 | — | Bond | $9,500,000 | $7,000,000 | -2,500,000 | $8,977 | $6,900 | -$2,077 | 2017-05-12 |
|---|
| Q1 2017 | EZCORP INC
CUSIP 302301AB2 | — | Bond | $13,000,000 | $11,500,000 | -1,500,000 | $12,515 | $10,690 | -$1,825 | 2017-05-12 |
|---|
| Q1 2017 | HORNBECK OFFSHORE SVCS INC N
CUSIP 440543AN6 | — | Bond | $5,000,000 | $3,000,000 | -2,000,000 | $3,595 | $1,988 | -$1,607 | 2017-05-12 |
|---|
| Q1 2017 | COWEN GROUP INC NEW
CUSIP 223622AB7 | — | Bond | $27,000,000 | $25,500,000 | -1,500,000 | $27,045 | $25,867 | -$1,178 | 2017-05-12 |
|---|
| Q1 2017 | ENERNOC INC
CUSIP 292764AB3 | — | Bond | $13,500,000 | $11,500,000 | -2,000,000 | $10,551 | $9,911 | -$640 | 2017-05-12 |
|---|
| Q1 2017 | NEVRO CORP
CUSIP 64157FAA1 | — | Bond | $12,200,000 | $11,200,000 | -1,000,000 | $13,052 | $13,595 | +$543 | 2017-05-12 |
|---|